![]() |
Volumn 16, Issue 1, 2001, Pages 23-27
|
Enhancement of serotoninergic function - A sometimes insufficient cause of antidepressant action
|
Author keywords
[No Author keywords available]
|
Indexed keywords
5,7 DIHYDROXYTRYPTAMINE;
ALPHA 1 ADRENERGIC RECEPTOR;
ALPHA 2 ADRENERGIC RECEPTOR;
ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT;
ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;
AMFEBUTAMONE;
ANTIDEPRESSANT AGENT;
CATECHOLAMINE;
CITALOPRAM;
CLOMIPRAMINE;
CLONIDINE;
DESIPRAMINE;
MIANSERIN;
MIRTAZAPINE;
MONOAMINE;
MONOAMINE OXIDASE INHIBITOR;
NEUROTRANSMITTER;
NORADRENALIN;
PAROXETINE;
POSTSYNAPTIC RECEPTOR;
PRESYNAPTIC RECEPTOR;
SEROTONIN;
SEROTONIN 1 RECEPTOR;
SEROTONIN 2 RECEPTOR;
SEROTONIN UPTAKE INHIBITOR;
TRICYCLIC ANTIDEPRESSANT AGENT;
TRYPTOPHAN;
UNINDEXED DRUG;
VENLAFAXINE;
ANIMAL CELL;
ANIMAL TISSUE;
ARTICLE;
CONTROLLED STUDY;
DEPRESSION;
DOSE RESPONSE;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG POTENCY;
FATIGUE;
HIPPOCAMPUS;
HUMAN;
HYPERTENSION;
NEUROTRANSMISSION;
NONHUMAN;
NORADRENALIN RELEASE;
PRIORITY JOURNAL;
PYRAMIDAL NERVE CELL;
RAT;
SEDATION;
SEROTONIN RELEASE;
SEROTONINERGIC NERVE CELL;
SEROTONINERGIC SYSTEM;
|
EID: 0035108012
PISSN: 08856222
EISSN: None
Source Type: Journal
DOI: 10.1002/hup.179 Document Type: Article |
Times cited : (16)
|
References (26)
|